Kodiak sciences inc. (KOD)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16
Cash flows from operating activities
Net loss

-47,365

-41,443

-27,936

-17,132

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

538

490

549

257

Non-cash interest expense and amortization of debt discount and issuance cost

0

5,482

1,161

0

Change in fair value of redeemable convertible preferred stock warrant liability

0

2,700

1,260

0

Change in fair value of derivative instrument

0

1,988

0

0

Extinguishment of debt

-

-5,479

-

-

Stock-based compensation

6,110

2,665

275

272

Amortization (accretion) of premium (discount) on marketable securities

241

-

-

-

Amortization of operating lease right-of-use asset

373

-

-

-

Changes in assets and liabilities:
Prepaid expenses and other current assets

168

1,995

-368

-270

Other assets

4,511

0

-8

-35

Accounts payable

1,569

-2,323

2,282

23

Accrued and other current liabilities

4,932

-2,105

4,330

242

Operating lease liability

-383

-

-

-

Other liabilities

0

31

48

-14

Net cash used in operating activities

-39,146

-29,031

-17,655

-16,047

Cash flows from investing activities
Purchase of property and equipment

437

78

209

771

Deposits on property and equipment

-

503

-

-

Purchase of marketable securities

150,961

-

-

-

Maturities of marketable securities

14,400

-

-

-

Net cash used in investing activities

-136,998

-581

-209

-771

Cash flows from financing activities
Proceeds from issuance of common stock, net of offering costs

297,616

83,755

-

-

Proceeds from issuance of common stock upon options exercise

2,287

49

3

5

Payments for restricted stock units, net of taxes withheld

132

-

-

-

Payments for repurchase of early exercised stock options

-

-

-

4

Proceeds from issuance of convertible notes (includes $9,560 and $8,000 from related parties for the years ended December 31, 2018 and 2017, respectively)

0

33,000

10,000

0

Debt issuance cost

0

140

181

0

Principal payments of capital lease

48

108

97

62

Principal payments of tenant improvement allowance payable

36

85

88

-

Principal payments of tenant improvement allowance payable

-

-

-

59

Net cash provided by financing activities

299,687

116,471

9,637

-120

Net increase (decrease) in cash, cash equivalents and restricted cash

123,543

86,859

-8,227

-16,938

Supplemental cash flow information:
Cash paid for interest

8

19

24

6

Supplemental disclosures of non-cash investing and financing information:
Operating lease right-of-use asset obtained in exchange for operating lease liability

2,163

-

-

-

Unpaid offering costs

459

205

-

-

Offering costs paid in restricted stock awards

-

91

-

-

Purchase of property and equipment under accounts payable

-

-

-

731

Derivative instrument related to convertible notes

-

6,603

-

0

Redeemable convertible preferred stock warrant issued in connection with convertible notes

0

0

1,040

0

Acquisition of equipment through capital lease

0

0

73

246